img

Global Oral Vaccines Market Segment Research Report 2024


Published on: 2024-01-04 | No of Pages : 420 | Industry : Medical Devices & Consumables Research Center

Publisher : MRX | Format : PDF

Global Oral Vaccines Market Segment Research Report 2024

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global Oral Vaccines Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Oral Vaccines industry at home and abroad, estimate the overall market scale of the Oral Vaccines industry and the market share of major countries, Oral Vaccines industry, and study and judge the downstream market demand of Oral Vaccines through systematic research, Analyze the competition pattern of Oral Vaccines, so as to help solve the pain points of various stakeholders in Oral Vaccines industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Oral Vaccines Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Oral Vaccines Market?
GlaxoSmithKline
PaxVax
Merial
Pfizer
Merck
Sanofi
Crucell
Quimica Suiza
Immunitor
Hualan Biological Engineering
Serum Institute of India
BB-NCIPD
Vaxart
Shantha Biotechnics
Crucell (Janssen Global Services
Major Type of Oral Vaccines Covered in XYZResearch report
Rotavirus Vaccine
Cholera Vaccine
Polio Vaccine
Others
Application Segments Covered in XYZResearch Market
Infant
Children
Adults

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Oral Vaccines Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Oral Vaccines Market by Value
2.2.1 Global Oral Vaccines Revenue by Type
2.2.2 Global Oral Vaccines Market by Value (%)
2.3 Global Oral Vaccines Market by Production
2.3.1 Global Oral Vaccines Production by Type
2.3.2 Global Oral Vaccines Market by Production (%)

3. The Major Driver of Oral Vaccines Industry
3.1 Historical & Forecast Global Oral Vaccines Demand
3.2 Largest Application for Oral Vaccines (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Oral Vaccines Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Oral Vaccines Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Oral Vaccines Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Oral Vaccines Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Oral Vaccines Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Oral Vaccines Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Oral Vaccines Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Oral Vaccines Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Oral Vaccines Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Oral Vaccines Average Price Trend
12.1 Market Price for Each Type of Oral Vaccines in US (2018-2022)
12.2 Market Price for Each Type of Oral Vaccines in Europe (2018-2022)
12.3 Market Price for Each Type of Oral Vaccines in China (2018-2022)
12.4 Market Price for Each Type of Oral Vaccines in Japan (2018-2022)
12.5 Market Price for Each Type of Oral Vaccines in India (2018-2022)
12.6 Market Price for Each Type of Oral Vaccines in Korea (2018-2022)
12.7 Market Price for Each Type of Oral Vaccines in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Oral Vaccines Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Oral Vaccines

14. Oral Vaccines Competitive Landscape
14.1 GlaxoSmithKline
14.1.1 GlaxoSmithKline Company Profiles
14.1.2 GlaxoSmithKline Product Introduction
14.1.3 GlaxoSmithKline Oral Vaccines Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 PaxVax
14.2.1 PaxVax Company Profiles
14.2.2 PaxVax Product Introduction
14.2.3 PaxVax Oral Vaccines Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Merial
14.3.1 Merial Company Profiles
14.3.2 Merial Product Introduction
14.3.3 Merial Oral Vaccines Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Pfizer
14.4.1 Pfizer Company Profiles
14.4.2 Pfizer Product Introduction
14.4.3 Pfizer Oral Vaccines Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Merck
14.5.1 Merck Company Profiles
14.5.2 Merck Product Introduction
14.5.3 Merck Oral Vaccines Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Sanofi
14.6.1 Sanofi Company Profiles
14.6.2 Sanofi Product Introduction
14.6.3 Sanofi Oral Vaccines Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Crucell
14.7.1 Crucell Company Profiles
14.7.2 Crucell Product Introduction
14.7.3 Crucell Oral Vaccines Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Quimica Suiza
14.8.1 Quimica Suiza Company Profiles
14.8.2 Quimica Suiza Product Introduction
14.8.3 Quimica Suiza Oral Vaccines Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Immunitor
14.9.1 Immunitor Company Profiles
14.9.2 Immunitor Product Introduction
14.9.3 Immunitor Oral Vaccines Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Hualan Biological Engineering
14.10.1 Hualan Biological Engineering Company Profiles
14.10.2 Hualan Biological Engineering Product Introduction
14.10.3 Hualan Biological Engineering Oral Vaccines Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Serum Institute of India
14.12 BB-NCIPD
14.13 Vaxart
14.14 Shantha Biotechnics
14.15 Crucell (Janssen Global Services
15. Conclusion
16. Methodology and Data Source


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Oral Vaccines Industry (Volume)
Figure 2. Oral Vaccines Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Oral Vaccines Revenue in 2022
Figure 5. US Oral Vaccines Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Oral Vaccines Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Oral Vaccines Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Oral Vaccines Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Oral Vaccines Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Oral Vaccines Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Oral Vaccines Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Oral Vaccines Revenue, by Type (Million USD) (2018-2028)
Table 4. Oral Vaccines Production, by Type (K Unit) (2018-2028)
Table 5. Oral Vaccines Demand (K Unit) by Application (2018-2028)
Table 6. Oral Vaccines Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Oral Vaccines Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Oral Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Oral Vaccines in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Oral Vaccines in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Oral Vaccines in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Oral Vaccines in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Oral Vaccines in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Oral Vaccines in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Oral Vaccines in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. GlaxoSmithKline Profiles
Table 61. GlaxoSmithKline Oral Vaccines Product Introduction
Table 62. GlaxoSmithKline Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. GlaxoSmithKline Strategic initiatives
Table 64. PaxVax Profiles
Table 65. PaxVax Oral Vaccines Product Introduction
Table 66. PaxVax Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. PaxVax Strategic initiatives
Table 68. Merial Profiles
Table 69. Merial Oral Vaccines Product Introduction
Table 70. Merial Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Merial Strategic initiatives
Table 72. Pfizer Profiles
Table 73. Pfizer Oral Vaccines Product Introduction
Table 74. Pfizer Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Pfizer Strategic initiatives
Table 76. Merck Profiles
Table 77. Merck Oral Vaccines Product Introduction
Table 78. Merck Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Merck Strategic initiatives
Table 80. Sanofi Profiles
Table 81. Sanofi Oral Vaccines Product Introduction
Table 82. Sanofi Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Sanofi Strategic initiatives
Table 84. Crucell Profiles
Table 85. Crucell Oral Vaccines Product Introduction
Table 86. Crucell Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Crucell Strategic initiatives
Table 88. Quimica Suiza Profiles
Table 89. Quimica Suiza Oral Vaccines Product Introduction
Table 90. Quimica Suiza Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Quimica Suiza Strategic initiatives
Table 92. Immunitor Profiles
Table 93. Immunitor Oral Vaccines Product Introduction
Table 94. Immunitor Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Immunitor Strategic initiatives
Table 97. Hualan Biological Engineering Profiles
Table 98. Hualan Biological Engineering Oral Vaccines Product Introduction
Table 99. Hualan Biological Engineering Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Hualan Biological Engineering Strategic initiatives
Table 101. Serum Institute of India Profiles
Table 102. Serum Institute of India Oral Vaccines Product Introduction
Table 103. Serum Institute of India Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Serum Institute of India Strategic initiatives
Table 105. BB-NCIPD Profiles
Table 106. BB-NCIPD Oral Vaccines Product Introduction
Table 107. BB-NCIPD Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. BB-NCIPD Strategic initiatives
Table 109. Vaxart Profiles
Table 110. Vaxart Oral Vaccines Product Introduction
Table 111. Vaxart Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Vaxart Strategic initiatives
Table 113. Shantha Biotechnics Profiles
Table 114. Shantha Biotechnics Oral Vaccines Product Introduction
Table 115. Shantha Biotechnics Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Shantha Biotechnics Strategic initiatives
Table 117. Crucell (Janssen Global Services Profiles
Table 118. Crucell (Janssen Global Services Oral Vaccines Product Introduction
Table 119. Crucell (Janssen Global Services Oral Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Crucell (Janssen Global Services Strategic initiatives